|Articles|February 1, 2017 (Updated: November 15, 2020)
- Pharmaceutical Executive-02-01-2017
- Volume 37
- Issue 2
Pharmaceutical Executive, February 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive February 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 9 years ago
Region in Reform? Access Pains and Gains in Latin Americaabout 9 years ago
CMED: The ‘Curupira’ of Brazil’s Pharma Marketabout 9 years ago
The Trouble with Pharma Partnerships ... And How to Fix Themabout 9 years ago
Reducing the Risk of Noncomplianceabout 9 years ago
When You Need Experts, Use Themabout 9 years ago
Pricing Pressures and Policy Changesabout 9 years ago
Not Your Typical Pharma Datelineabout 9 years ago
Market Access: Current and Future Statesabout 9 years ago
Market Access: A UK Perspectiveabout 9 years ago
Country Report: SingaporeNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
4
Pharma Leadership Roundup: Sarepta Therapeutics CEO Announces Retirement, Rivus Pharmaceuticals Appoints New CEO
5